An ALK rearrangement analysis was performed in 195 cases (140 adenocarcinomas, 50 squamous cell carcinomas, 3 adenosquamous carcinomas, 2 large-cell carcinomas). The gene discussed is ALK; the disease is adenocarcinoma.